Circular peptides as a new class of ligands to modulate cannabinoid type 2 receptor signaling     (#372)
    
  
  
                                                                              
  Natasa Tomasevic
      1
  
, 
  Fabiola S. Emser
      1
  
, 
  Edin Muratspahic
      1
      2
  
, 
  Manuel Felkl
      3
  
, 
  Christian F.W. Becker
      3
  
, 
  Christian W. Gruber
      1
  
    
              - Institute for Physiology and Pharmacology, Medical University of Vienna, Vienna, Austria
 
              - Institute for Protein Design, University of Washington, Seattle, Washington, USA
 
              - Institute of Biological Chemistry, University of Vienna, Vienna, Austria
 
          
   
 
  
     
      Publish consent withheld      
  
          - Muratspahić, E. et al. Nature-Derived Peptides: A Growing Niche for GPCR Ligand Discovery. Trends in Pharmacological Sciences 40, 309-326 (2019).
 
          - Muratspahić, E. et al. Harnessing cyclotides to design and develop novel peptide GPCR ligands. RSC Chemical Biology 1, 177-191 (2020).
 
          - Li, X. et al. Crystal structure of the human cannabinoid receptor CB2. Cell 176, (2019).
 
          - Di Marzo, V. New approaches and challenges to targeting the endocannabinoid system. Nature Reviews Drug Discovery 17, 623–639 (2018).